Trial Profile
An open-label, multiple-dose study to evaluate the pharmacokinetics, pharmacodynamics, and safety of intravenous ilaprazole in healthy Chinese volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Apr 2016
Price :
$35
*
At a glance
- Drugs Ilaprazole (Primary)
- Indications Gastro-oesophageal reflux; Peptic ulcer; Reflux oesophagitis
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Livzon Pharmaceuticals
- 20 Apr 2016 New trial record
- 11 Apr 2016 Results (n=10) published in the Clinical Drug Investigation.